Latest news with #BioSigTechnologies
Yahoo
27-05-2025
- Business
- Yahoo
BioSig Technologies signs definitive share exchange agreement with Streamex
BioSig Technologies (BSGM) announced it has signed a definitive share exchange agreement with Streamex Exchange, a privately held company specializing in the tokenization of real-world assets, with a focus on bringing commodities on-chain. 'The signing of the definitive agreement represents a major milestone for both Streamex and BioSig, propelling the business combination forward, and fast-tracking the growth of Streamex's tokenization business. During this transaction, Streamex has made significant progress with some very exciting developments expected to be shared in the coming weeks,' the company stated. BioSig's CEO Anthony Amato commented, 'After a year marked by intense focus, disciplined execution, and steadfast commitment, I'm pleased to announce that we have signed a definitive agreement to combine with Streamex. This marks a pivotal milestone in our ongoing strategy to restore and build long-term shareholder value. This journey hasn't been without its challenges-but it has also been defined by toughness, learning, and progress. But today, we enter what promises to be the most transformational chapter in our company's history. I want to thank our incredible employees, our leadership team, and our board of directors for their unwavering dedication and resilience throughout this journey. And to our shareholders: this is the moment we've been working toward. We believe this business combination significantly strengthens the foundation of your investment and positions us for sustained momentum and future growth.' Henry McPhie, incoming CEO of the combined company added, 'Since announcing the LOI for the transaction, we've received an overwhelmingly positive response from the market, reflecting strong investor confidence in the value and potential of this transaction. With the signing of the definitive agreement, we're thrilled to move ahead with the BioSig team to complete the combination and bring Streamex to the public market.' Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today's best-performing stocks on TipRanks >> Read More on BSGM: Disclaimer & DisclosureReport an Issue BioSig Technologies Delays Q1 2025 Filing BioSig Technologies Regains Nasdaq Compliance BioSig Technologies enters LOI to merge with Streamex Exchange BioSig Technologies Delays Form 10-K Filing BioSig Technologies confirms full compliance with Nasdaq requirements Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
26-05-2025
- Business
- Yahoo
BioSig Stock Surges Following Share Exchange Deal With Streamex
BioSig Technologies, Inc. BSGM recently entered into a definitive share exchange agreement with Streamex Exchange Corporation (Streamex), a private company focused on the tokenization of real-world assets. This strategic move marks BioSig's entry into the rapidly growing blockchain and digital asset sector, with an emphasis on bringing commodity markets on-chain. With this agreement, BioSig is positioning itself to tap into the growing global commodities market through innovative blockchain solutions. This merger not only diversifies BioSig's business model but also aligns it with the future of decentralized finance, unlocking new opportunities for growth and market relevance in the digital age. Following the announcement, shares of the company soared 24.4% and closed at $5.28 on Friday. In the year-to-date period, BSGM's shares have gained 254.4% against the industry's 10.5% decline. The S&P 500 decreased 1.9% in the same time frame. This deal can significantly boost BSGM's business in the long run by transforming its core identity from a traditional medtech company into a diversified player in the blockchain and digital asset space. By integrating Streamex's platform for real-world asset tokenization, especially in commodities, BSGM gains access to a high-growth, trillion-dollar market far beyond its original scope. This diversification can open new revenue streams, attract fintech-focused investors, and enhance the company's strategic value. Meanwhile, BSGM currently has a market capitalization of $144.1 million. The company expects its earnings to improve 73.3% in 2025 year over year. Image Source: Zacks Investment Research Real-world asset tokenization is the process of converting physical or traditional assets, such as real estate, commodities, or artwork, into digital tokens on a blockchain. These tokens represent ownership or rights to the underlying asset, enabling easier transfer, fractional ownership, and increased liquidity. BSGM is likely to benefit from this deal by gaining access to Streamex's innovative blockchain technology and expertise in real-world asset tokenization, allowing it to diversify beyond medical technology into the fast-growing digital asset and commodities markets. Under the terms of the agreement, Streamex will become a wholly owned subsidiary of BioSig through a share exchange transaction. All outstanding shares of Streamex will be exchanged for new shares of BioSig common stock. Streamex shareholders will receive 75% of BioSig's fully diluted common stock in exchange for all Streamex shares. At closing, they will get 19.9% initially (per Nasdaq rules), and the remaining shares, up to 75%, will be issued after BioSig shareholders approve the deal. Post-approval, existing BioSig shareholders will retain 25% ownership in the combined company. Per a report by MarketsandMarkets, the global tokenization market size was valued at $2.3 billion in 2021, and it is projected to reach $5.6 billion by the end of 2026 at a CAGR of 19.0% during the forecast period. The tokenization market is driven by the growing demand for increased liquidity, transparency, and accessibility in traditional asset markets. Advances in blockchain technology enable the digitization of real-world assets, making it easier to trade, fractionalize, and transfer ownership globally. BSGM carries a Zacks Rank #2 (Buy) at present. Some other top-ranked stocks in the broader medical space that have announced quarterly results are CVS Health Corporation CVS, Integer Holdings Corporation ITGR and AngioDynamics ANGO. CVS Health, carrying a Zacks Rank of 2, reported first-quarter 2025 adjusted earnings per share (EPS) of $2.25, beating the Zacks Consensus Estimate by 31.6%. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Revenues of $94.59 billion outpaced the consensus mark by 1.8%. CVS Health has a long-term estimated growth rate of 11.4%. Its earnings surpassed estimates in each of the trailing four quarters, with an average surprise of 18.1%. Integer Holdings reported first-quarter 2025 adjusted EPS of $1.31, beating the Zacks Consensus Estimate by 3.2%. Revenues of $437.4 million surpassed the Zacks Consensus Estimate by 1.3%. It currently sports a Zacks Rank of 1. Integer Holdings has a long-term estimated growth rate of 18.4%. ITGR's earnings surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 2.8%. AngioDynamics, currently sporting a Zacks Rank #1, reported a third-quarter fiscal 2025 adjusted EPS of 3 cents against the Zacks Consensus Estimate of a 13-cent loss. Revenues of $72 million beat the Zacks Consensus Estimate by 2%. ANGO has an estimated fiscal 2026 earnings growth rate of 27.8% compared with the S&P 500 Composite's 10.5% growth. AngioDynamics' earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 70.9%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AngioDynamics, Inc. (ANGO) : Free Stock Analysis Report CVS Health Corporation (CVS) : Free Stock Analysis Report Integer Holdings Corporation (ITGR) : Free Stock Analysis Report Biosig Technologies, Inc. (BSGM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
25-05-2025
- Business
- Yahoo
BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition
BioSig Technologies, Inc. (NASDAQ:BSGM) has entered a definitive share exchange agreement with Streamex Exchange Corp, which initiates a bold shift from medical technology to blockchain-powered real-world asset (RWA) tokenization. As per the agreement, Streamex will become a wholly owned subsidiary with its shareholders expected to hold 75% of BioSig's fully diluted common stock, pending shareholder approval. A cardiac surgeon demonstrating a simulated ablation procedure with a signal processing platform. In the combined entity, Streamex's co-founder, Henry McPhie, will step in as CEO, and Morgan Lekstrom will take on the role of Chairman. Current BioSig Technologies, Inc. (NASDAQ:BSGM) CEO Anthony Amato will transition to a board role, signaling the company's retreat from its original medical tech identity. Complying with regulations, the company has initially issued 19.9% of shares to Streamex investors and awaits full approval. The transaction has attracted strategic advisors with high profiles, including Frank Giustra, the founder of Wheaton Precious Metals and GoldCorp, indicating the noteworthiness of the company's entry into the $142.85 trillion global commodity sector. Leveraging its vertically integrated infrastructure, Streamex can gain a competitive edge with tokenization poised to address inefficiencies in commodity trading and settlement. On the other hand, BioSig Technologies, Inc. (NASDAQ:BSGM)'s radical shift introduces considerable uncertainty. Existing shareholder equity is diluted, and the company is also exposed to the operational risks inherent in shifting industries. Additionally, the technical specifications regarding Streamex's blockchain framework have also not been disclosed yet. Notably, while the institutional transaction in BioSig Technologies, Inc. (NASDAQ:BSGM) has increased by 218.41%, the insider transaction remains neutral at 0.00% over the last six months. BSGM could be a potential investment opportunity. But our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSGM and that has 100x upside potential, check out our report about the READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-05-2025
- Business
- Yahoo
BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition
BioSig Technologies, Inc. (NASDAQ:BSGM) has entered a definitive share exchange agreement with Streamex Exchange Corp, which initiates a bold shift from medical technology to blockchain-powered real-world asset (RWA) tokenization. As per the agreement, Streamex will become a wholly owned subsidiary with its shareholders expected to hold 75% of BioSig's fully diluted common stock, pending shareholder approval. A cardiac surgeon demonstrating a simulated ablation procedure with a signal processing platform. In the combined entity, Streamex's co-founder, Henry McPhie, will step in as CEO, and Morgan Lekstrom will take on the role of Chairman. Current BioSig Technologies, Inc. (NASDAQ:BSGM) CEO Anthony Amato will transition to a board role, signaling the company's retreat from its original medical tech identity. Complying with regulations, the company has initially issued 19.9% of shares to Streamex investors and awaits full approval. The transaction has attracted strategic advisors with high profiles, including Frank Giustra, the founder of Wheaton Precious Metals and GoldCorp, indicating the noteworthiness of the company's entry into the $142.85 trillion global commodity sector. Leveraging its vertically integrated infrastructure, Streamex can gain a competitive edge with tokenization poised to address inefficiencies in commodity trading and settlement. On the other hand, BioSig Technologies, Inc. (NASDAQ:BSGM)'s radical shift introduces considerable uncertainty. Existing shareholder equity is diluted, and the company is also exposed to the operational risks inherent in shifting industries. Additionally, the technical specifications regarding Streamex's blockchain framework have also not been disclosed yet. Notably, while the institutional transaction in BioSig Technologies, Inc. (NASDAQ:BSGM) has increased by 218.41%, the insider transaction remains neutral at 0.00% over the last six months. BSGM could be a potential investment opportunity. But our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than BSGM and that has 100x upside potential, check out our report about the READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None.
Associated Press
24-05-2025
- Business
- Associated Press
BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.
Los Angeles, CA and Vancouver, BC, May 23, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ('BioSig' or the 'Company'), a medical technology company, today announced it has signed a definitive share exchange agreement with Streamex Exchange Corporation ('Streamex'), a privately held company specializing in the tokenization of real-world assets, with a focus on bringing commodities on-chain. The signing of the definitive agreement represents a major milestone for both Streamex and BioSig, propelling the business combination forward, and fast-tracking the growth of Streamex's tokenization business. During this transaction, Streamex has made significant progress with some very exciting developments expected to be shared in the coming weeks. Key Highlights of the Transaction: BioSig's CEO Anthony Amato commented, 'After a year marked by intense focus, disciplined execution, and steadfast commitment, I'm pleased to announce that we have signed a definitive agreement to combine with Streamex. This marks a pivotal milestone in our ongoing strategy to restore and build long-term shareholder value. This journey hasn't been without its challenges—but it has also been defined by toughness, learning, and progress. But today, we enter what promises to be the most transformational chapter in our company's history. I want to thank our incredible employees, our leadership team, and our board of directors for their unwavering dedication and resilience throughout this journey. And to our shareholders: this is the moment we've been working toward. We believe this business combination significantly strengthens the foundation of your investment and positions us for sustained momentum and future growth.' Henry McPhie, incoming CEO of the combined company added, 'Since announcing the LOI for the transaction, we've received an overwhelmingly positive response from the market, reflecting strong investor confidence in the value and potential of this transaction. With the signing of the definitive agreement, we're thrilled to move ahead with the BioSig team to complete the combination and bring Streamex to the public market.' Strategic Advisor Additions Post Closing About Streamex Exchange Corporation Streamex is a real-world asset (RWA) tokenization company focused in the commodities space. With the goal to bring commodity markets on chain, Streamex has developed primary issuance and exchange infrastructure that will revolutionize commodity finance. Streamex is led by a group of highly successful and seasoned executives from financial, commodities and blockchain industries. Streamex believes the future of finance lies in tokenization, innovative investment strategies, and decentralized markets. By merging advanced financial technologies with blockchain transparency, Streamex has created infrastructure and solutions that enhance liquidity, accessibility, and efficiency. Streamex's goal is to bridge the gap between traditional finance and the digital economy, unlocking new opportunities for investors and institutions worldwide. Terms of Share Exchange Immediately after the Closing, the Board of directors of BioSig will be comprised of six members, four designated by BioSig. who are Anthony Amato, Chris Baer, Donald F. Browne, Steven E. Abelman and two designated by Streamex, who are Mr. McPhie and Mr. Lekstrom (who will also be Chairman of the BioSig Board). Forward Looking statements This press release contains 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential' or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions, and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements, depending on factors including whether the Company will be able to realize the benefits of the completed transaction described herein, whether shareholder approval of the transaction will be obtained and whether the Company will be able to maintain compliance with Nasdaq's listing criteria in connection with the contemplated transaction and otherwise. For a discussion of other risks and uncertainties, and other important factors, any of which could cause BioSig's actual results to differ from those contained in forward-looking statements, see BioSig's filings with the Securities and Exchange Commission, including the section titled 'Risk Factors' in BioSig's Annual Report on Form 10-K, filed with the SEC on April 15, 2025. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise, except as required by law. 1 According to Statista, the global commodities market is valued at approximately US$142.85 trillion. Source: Statista, Global Commodities Market Outlook Todd Adler BioSig Technologies, Inc. Investor Relations 12424 Wilshire Blvd Ste 745 Los Angeles, CA 90025 [email protected] 203–409–5444, x104 Anthony Amato Chief Executive Officer [email protected] Henry McPhie Co-Founder & CEO of Streamex [email protected]
